ESS
48
-2
QCOM
55
2
ADT
61
11
ECL
55
-4
ALLE
35
3
HRB
45
-2
PG
43
2
GIS
38
3
KEY
43
4
VZ
34
4
BEN
30
2
EBAY
50
2
CVX
40
3
TRIP
85
9
CMCSA
35
3
CAT
62
3
AZO
50
5
URBN
66
6
AMAT
59
4
STX
49
3
ESS
48
-2
QCOM
55
2
ADT
61
11
ECL
55
-4
ALLE
35
3
HRB
45
-2
PG
43
2
GIS
38
3
KEY
43
4
VZ
34
4
BEN
30
2
EBAY
50
2
CVX
40
3
TRIP
85
9
CMCSA
35
3
CAT
62
3
AZO
50
5
URBN
66
6
AMAT
59
4
STX
49
3
Financhill
Back

Veracyte Stock Predictions

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]
Buy
65

VCYT
Veracyte

Last Price:
$40.55
Seasonality Move:
-5.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]

Veracyte Stock Forecast

  • Over the next 52 weeks, Veracyte has on average historically risen by 21.9% based on the past 11 years of stock performance.
  • Veracyte has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
  • Is Veracyte Stock Undervalued?
    The current Veracyte [VCYT] share price is $40.58. The Score for VCYT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Veracyte Stock Go Up Next Year?

  • Over the next 52 weeks, Veracyte has on average historically risen by 21.9% based on the past 11 years of stock performance.

Veracyte Stock Rating

Buy
65
Veracyte (VCYT) is a Buy

Is Veracyte overpriced?

  • Veracyte has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%

Veracyte Stock Price History

Is VCYT stock going to rise?

  • The current trend is moderately bearish and VCYT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com

52-Week Data

52-Week High:
46.00
52-Week Low:
18.61

Prediction Charts

Market Cap:
3.1B
Price in USD:
40.58
Volume:
2.6M
Beta:
1.52

Technical Analysis

SMA50:
40.88
SMA100:
36.86
SMA200:
29.77
52-Wk Change:
58.52%

Stock Predictions

  • Is Veracyte stock public?
    Yes, Veracyte is a publicly traded company.
  • What is the Veracyte stock quote today?
    The Veracyte stock price is 40.58 USD today.
  • How to buy Veracyte stock online?
    You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 40.06 40.12 40.85 39.74
Dec-30 39.53 40.00 40.45 38.89
Dec-31 40.23 39.60 40.61 39.44
Jan-2 40.08 40.44 40.91 39.38
Jan-3 40.50 41.91 41.95 40.24
Jan-6 42.02 43.41 44.50 42.01
Jan-7 43.55 42.49 44.37 42.10
Jan-8 42.49 43.78 43.95 41.80
Jan-10 42.35 41.54 42.56 40.50
Jan-13 41.69 42.78 43.11 41.53
Jan-14 43.09 41.06 43.53 40.25
Jan-15 42.36 41.72 43.18 41.47
Jan-16 41.61 41.10 41.98 40.29
Jan-17 41.74 40.58 41.77 40.45

Veracyte Earnings

Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Veracyte Forecast Revenue Growth

Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.28 per share.

* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.